Fruquintinib as Second-line Treatment for Advanced/Metastatic Biliary Tract Adenocarcinoma
Clinical trial NCT04156958 · UNKNOWN
Trial details
- NCT number
- NCT04156958
- Sponsor
- Sichuan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-01
- Primary completion
- 2021-09-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.